178 related articles for article (PubMed ID: 20488818)
1. Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.
Vaziri ND; Kim HJ; Moradi H; Farmand F; Navab K; Navab M; Hama S; Fogelman AM; Quiroz Y; Rodriguez-Iturbe B
Nephrol Dial Transplant; 2010 Nov; 25(11):3525-34. PubMed ID: 20488818
[TBL] [Abstract][Full Text] [Related]
2. ApoA-1 mimetic peptide reverses uremia-induced upregulation of pro-atherogenic pathways in the aorta.
Vaziri ND; Bai Y; Yuan J; Said HL; Sigala W; Ni Z
Am J Nephrol; 2010; 32(3):201-211. PubMed ID: 20639628
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.
Morgantini C; Imaizumi S; Grijalva V; Navab M; Fogelman AM; Reddy ST
Diabetes; 2010 Dec; 59(12):3223-8. PubMed ID: 20826564
[TBL] [Abstract][Full Text] [Related]
4. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
Sherman CB; Peterson SJ; Frishman WH
Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
[TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice.
Sastre C; Rubio-Navarro A; Buendía I; Gómez-Guerrero C; Blanco J; Mas S; Egido J; Blanco-Colio LM; Ortiz A; Moreno JA
PLoS One; 2013; 8(12):e83713. PubMed ID: 24386260
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
9. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.
Vaziri ND; Moradi H; Pahl MV; Fogelman AM; Navab M
Kidney Int; 2009 Aug; 76(4):437-44. PubMed ID: 19471321
[TBL] [Abstract][Full Text] [Related]
10. [Differential expressions of lipid metabolism related genes in the liver of young apoE knockout mice].
Ye HY; Yin M; Shang YJ; Dai XD; Zhang SQ; Jing W; Du HQ; Zhang L; Pan J
Sheng Li Xue Bao; 2008 Feb; 60(1):51-8. PubMed ID: 18288358
[TBL] [Abstract][Full Text] [Related]
11. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
[TBL] [Abstract][Full Text] [Related]
12. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.
Jahagirdar R; Zhang H; Azhar S; Tobin J; Attwell S; Yu R; Wu J; McLure KG; Hansen HC; Wagner GS; Young PR; Srivastava RA; Wong NC; Johansson J
Atherosclerosis; 2014 Sep; 236(1):91-100. PubMed ID: 25016363
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
Anantharamaiah GM; Garber DW; White CR
Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
[TBL] [Abstract][Full Text] [Related]
14. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
[TBL] [Abstract][Full Text] [Related]
16. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet.
Buga GM; Frank JS; Mottino GA; Hakhamian A; Narasimha A; Watson AD; Yekta B; Navab M; Reddy ST; Anantharamaiah GM; Fogelman AM
J Lipid Res; 2008 Jan; 49(1):192-205. PubMed ID: 17925450
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.
Wool GD; Reardon CA; Getz GS
J Lipid Res; 2008 Jun; 49(6):1268-83. PubMed ID: 18323574
[TBL] [Abstract][Full Text] [Related]
18. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.
Wool GD; Vaisar T; Reardon CA; Getz GS
J Lipid Res; 2009 Sep; 50(9):1889-900. PubMed ID: 19433476
[TBL] [Abstract][Full Text] [Related]
19. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice.
McGrath KC; Li X; Twigg SM; Heather AK
PLoS One; 2020; 15(1):e0226931. PubMed ID: 31914125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
